Diltiazem Hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70436-200 -
Package NDC
70436-200-04 -
Package NDC
70436-200-06 -
Application number
ANDA216439 -
SPL ID
58494981-80ca-63f9-e063-6294a90aef59 -
SPL set ID
f7137458-0db3-7ecd-e053-6394a90a5f95 -
UNII
OLH94387TE -
RxCUI
830874 -
RxCUI
830877 -
RxCUI
830879 -
RxCUI
830882 -
RxCUI
830897 -
RxCUI
830900
What the source publishes
- Labeler
- Slate Run Pharmaceuticals, LLC
- Active ingredients
- Diltiazem Hydrochloride
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Diltiazem Hydrochloride",
"splId": "58494981-80ca-63f9-e063-6294a90aef59",
"labels": [
{
"setId": "f7137458-0db3-7ecd-e053-6394a90a5f95",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f7137458-0db3-7ecd-e053-6394a90a5f95",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f7137458-0db3-7ecd-e053-6394a90a5f95"
}
],
"routes": [
"ORAL"
],
"labeler": "Slate Run Pharmaceuticals, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-200-04)",
"package_ndc": "70436-200-04",
"identifierStatus": "well-formed",
"marketing_start_date": "20230320"
},
{
"sample": false,
"description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-200-06)",
"package_ndc": "70436-200-06",
"identifierStatus": "well-formed",
"marketing_start_date": "20230320"
}
],
"productId": "70436-200_58494981-80ca-63f9-e063-6294a90aef59",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "70436-200",
"deaSchedule": null,
"genericName": "Diltiazem Hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DILTIAZEM HYDROCHLORIDE",
"strength": "420 mg/1"
}
],
"applicationNumber": "ANDA216439",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230320",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0370436197064",
"0370436199068",
"0370436200061",
"0370436196067",
"0370436200047",
"0370436198061",
"0370436196043",
"0370436199044",
"0370436197040",
"0370436198047",
"0370436195060",
"0370436195046"
],
"unii": [
"OLH94387TE"
],
"rxcui": [
"830874",
"830877",
"830879",
"830882",
"830897",
"830900"
],
"spl_set_id": [
"f7137458-0db3-7ecd-e053-6394a90a5f95"
],
"manufacturer_name": [
"Slate Run Pharmaceuticals, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70436-200_58494981-80ca-63f9-e063-6294a90aef59"